Cas:1263378-47-7 2-Bromo-4-isopropoxy-1-nitro-benzene manufacturer & supplier

Chemical Name:2-Bromo-4-isopropoxy-1-nitro-benzene

CAS.NO:1263378-47-7

Synonyms:2-Bromo-4-isopropoxy-1-nitro-benzene

Molecular Formula:C₉H₁₀BrNO₃

Molecular Weight:260.0846

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Bromo-4-isopropoxy-1-nitro-benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-4-isopropoxy-1-nitro-benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-4-isopropoxy-1-nitro-benzene Use and application,2-Bromo-4-isopropoxy-1-nitro-benzene technical grade,usp/ep/jp grade.

Related News: The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. 2-Bromo-4-isopropoxy-1-nitro-benzene manufacturer As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. 2-Bromo-4-isopropoxy-1-nitro-benzene supplier Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday. 2-Bromo-4-isopropoxy-1-nitro-benzene vendor The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. 2-Bromo-4-isopropoxy-1-nitro-benzene factory The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.